MEDPAL AI is trading at £6.39, up 6.58%, amid continued growth highlighted in its October 8 company update.
- Daily dispensing exceeded 2,300 prescriptions, worth approximately £300,000.
- Cash, near-cash assets and stock amounted to approximately £6.4 million.
- The update disclosed an indicative £8 million lender term sheet; no facility was agreed, and no equity fundraising was planned.